This study focused on the development of cholesterol-free fusogenic liposomes with different surface charge with
the aim of improving biofilm penetration. In vitro assessments of the liposomes included physical stability,
biocompatibility, fusion with microbial cells, and the ability to penetrate established biofilms. Using dynamic
light scattering, cholesterol-free, fusogenic liposomes were found to be < 200 nm in size with small size distribution (PDI < 0.1) and physically stable for a year when stored at 4◦C. Transmission electron microscopy
(TEM) images confirmed vesicular sizes for selected liposomal formulations. Liposomal ability to fuse with
microbial cells was assessed using lipid mixing and flow cytometer assays. Fusion levels were found to be higher
with Escherichia coli compared to Staphylococcus aureus and Candida albicans regardless of the liposomal charge.
Neutral liposomes exhibited highest fusion, followed by cationic and anionic liposomes, respectively. Our investigations demonstrated that fusion is a multifactorial process influenced by the chemical composition of the
liposomes, the liposomal surface charge, and components of the microbial cell envelope. Penetration and
retention within preformed S. aureus biofilms were assessed for liposomes with various surface charges. All liposomes, regardless of surface charge, were capable of penetrating and diffusing through the biofilm matrix.
However, cationic liposomes displayed greatest interaction and retention. Biocompatibility was confirmed
through haemolysis and cytotoxicity studies. The cholesterol-free fusogenic liposomes developed in this study
demonstrated promising potential as drug delivery systems for incorporating antimicrobial agents for biofilm
treatment.publishedVersio
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.